Anetac, a leader in protecting companies from identity-based vulnerabilities in hybrid environments, today announced the global rollout of Human Link Pro. This powerful new capability unifies the ...

GSK bought into the EOS-448 programme last year in a deal orchestrated by its chief scientific officer Hal Barron, who is leaving to join biotech startup Altos at the beginning of August.

"Every biotech or pharma company searching for the ... learning company Zymergen (bought by Ginkgo Bioworks in 2022), and Altos Labs, which focuses on longevity through biological reprogramming ...

SAN JOSE — Los Altos third baseman Darrion Wesley was up with the bases loaded, two out and his team trailing by a run in the top of the fifth Saturday. The count went 2 and 2 before the lefty ...

Krystal Biotech KRYS underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. Summarizing their recent assessments, the table below ...

Portage Biotech's PORT-7 showed >90% tumor growth inhibition with anti-PD1 combo in a murine mesothelioma model. PORT-7 single-agent activity outperformed anti-PD1 treatment alone; first-in-human ...

The Food and Drug Administration is projecting a more favorable stance toward biotech, emphasizing streamlined processes and accelerated approvals (“FDA Sends a Bullish Signal to Biotech ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

Octagon Therapeutics has thrown in the towel. The Novo Nordisk-allied autoimmune disease biotech is winding down after deprioritizing its lead program and running into unresolved biology questions.

Agnico Eagle Mines reports Q1-25 gold output of ~873,800 oz, with strong performance at core assets in Tier-1 regions. Read ...

Rather, with so much uncertainty, investors are prizing biotech companies that base their intellectual property and manufacturing in the U.S., which up until now often meant higher taxes.

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top ...